Lyric Website
2 known investors
Lyric Bio develops tissue-engineered bioreactors that use a proprietary laser-printed cellular substrate to grow high-density human cells and produce human immunoglobulin (IvIg, ScIg) from a single donor. The company aims to reduce Ig therapy's dependence on blood and plasma donations and enable scalable manufacturing of complex donor-derived biologics.
BiotechDeep TechHealthtech
Investors Β· 2
Frequently asked questions
- What does Lyric Website do?
- Lyric Bio develops tissue-engineered bioreactors that use a proprietary laser-printed cellular substrate to grow high-density human cells and produce human immunoglobulin (IvIg, ScIg) from a single donor. The company aims to reduce Ig therapy's dependence on blood and plasma donations and enable scalable manufacturing of complex donor-derived biologics.
- Who are Lyric Website's investors?
- Lyric Website's investors include Draper Associates, The Venture Collective.